...
机译:与甘氨酸转运蛋白-1抑制剂PF-03463275健康和精神分裂症受试者的电路,行为和神经塑性有关的剂量相关的靶标占用和影响
Department of Psychiatry Yale University School of Medicine;
Department of Radiology and Biomedical Imaging Yale University School of Medicine;
Department of Psychiatry Yale University School of Medicine;
Department of Psychiatry Yale University School of Medicine;
Department of Psychiatry Yale University School of Medicine;
Department of Psychiatry Yale University School of Medicine;
Cognition; Glycine transporter inhibitor; Long-term potentiation; Neuroplasticity; NMDA receptor; Positron emission tomography; Receptor occupancy; Schizophrenia;
机译:与甘氨酸转运蛋白-1抑制剂PF-03463275健康和精神分裂症受试者的电路,行为和神经塑性有关的剂量相关的靶标占用和影响
机译:甘氨酸转运蛋白-1抑制剂Bitopertin对精神分裂症相关的啮齿动物脑电图和听觉事件相关生物标志物的影响
机译:新型甘氨酸转运蛋白1(GlyT1)抑制剂ASP2535(4- [3-异丙基-5-(6-苯基-3-吡啶基)-4H-1,2,4-三唑-4-基] -2,1 (3-苯并二唑),可改善精神分裂症和阿尔茨海默氏病认知障碍动物模型的认知
机译:在健康和精神分裂症患者中剂量相关的靶标占据率及其对甘氨酸转运蛋白-1抑制剂PF-03463275的回路行为和神经可塑性的影响
机译:与甘氨酸转运蛋白-1抑制剂PF-03463275健康和精神分裂症受试者的电路,行为和神经塑性有关的剂量相关的靶标占用和影响